New Psychedelic ETF About To Hit the Market There is a new March 5, 2021 U.S. Securities Exchange Commission (SEC) filing that will allow investors to gain exposure to the psychedelic and cannabis industries. Read More adult use marijuana, cannabis, CBD, finance, healthcare, life sciences, medical marijuana, pharmaceuticals, pharmacy, psychedelic mushrooms, stock market, SECRon LantonMarch 9, 2021Psychedelic ETF, psychedelic, cannabis, Psychedelics Healthcare, medical cannabis, Hemp, CBD, SEC
